Kai Eichhorn

Summary

Country: Germany

Publications

  1. ncbi [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
    Barbara Gehler
    Department of Radiation Oncology, LMU Munchen, Marchioninistr, 15, 81377 Munchen, Germany
    Radiat Oncol 4:56. 2009
  2. ncbi Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition
    Ute Ganswindt
    Department of Radiation Oncology, University of Tubingen, Tubingen, Germany
    BMC Cancer 5:91. 2005
  3. ncbi [18F-fluorodeoxyglucose positron emission tomography in the diagnosis of lung cancer]
    R Bares
    Klinischen Abteilung Nuklearmedizin der Radiologischen Universitätsklinik Tübingen, Röntgenweg 13 15, D 72 076 Tübingen, Deutschland
    Acta Med Austriaca 29:171-5. 2002
  4. ncbi [Nuclear medicine diagnosis of the kidneys]
    R Bares
    Abteilung Nuklearmedizin, Universitatsklinikum Tubingen
    Radiologe 40:938-45. 2000
  5. ncbi Unusual distribution of red marrow mimicking chloroma in a patient with acute myelogenous leukemia
    M N Vogel
    Department of Diagnostic Radiology, Eberhard Karls University, Hoppe Seyler Strasse 3, 72076, Tubingen, Germany
    Skeletal Radiol 36:547-50. 2007
  6. ncbi [Evaluation of different breathing and contrast-protocols concerning quality and alignment in 18F-FDG PET/CT]
    M N Vogel
    Diagnostische Radiologie, Eberhard Karls Universitat Tubingen
    Rofo 179:72-9. 2007
  7. ncbi Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging
    A C Pfannenberg
    Department of Diagnostic Radiology, Eberhard Karls University Tuebingen, Hoppe Seyler Strasse 3, 72076 Tuebingen, Germany
    Br J Radiol 80:437-45. 2007
  8. ncbi Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol
    M Reimold
    Department of Nuclear Medicine PET Center, University of Tuebingen, Tuebingen, Germany
    Psychopharmacology (Berl) 190:241-9. 2007
  9. ncbi Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors
    S M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 34:54-9. 2007
  10. ncbi Lymph node gastrinoma in multiple endocrine neoplasia type 1 - a diagnostic challenge
    K Müssig
    Division of Endocrinology, Diabetology, Nephrology, Angiology, and Clinical Chemistry, Department of Internal Medicine, University Hospital of Tubingen, Tubingen, Germany
    Exp Clin Endocrinol Diabetes 116:554-7. 2008

Collaborators

Detail Information

Publications39

  1. ncbi [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
    Barbara Gehler
    Department of Radiation Oncology, LMU Munchen, Marchioninistr, 15, 81377 Munchen, Germany
    Radiat Oncol 4:56. 2009
    ....
  2. ncbi Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition
    Ute Ganswindt
    Department of Radiation Oncology, University of Tubingen, Tubingen, Germany
    BMC Cancer 5:91. 2005
    ..To overcome this limitation, we tested the feasibility of an intensity modulated radiation therapy (IMRT) protocol, taking under consideration the individual pelvic sentinel node drainage pattern by SPECT functional imaging...
  3. ncbi [18F-fluorodeoxyglucose positron emission tomography in the diagnosis of lung cancer]
    R Bares
    Klinischen Abteilung Nuklearmedizin der Radiologischen Universitätsklinik Tübingen, Röntgenweg 13 15, D 72 076 Tübingen, Deutschland
    Acta Med Austriaca 29:171-5. 2002
    ..New applications of PET may include non-invasive evaluation of tissue proliferation or hypoxia to predict individual prognosis or treatment response...
  4. ncbi [Nuclear medicine diagnosis of the kidneys]
    R Bares
    Abteilung Nuklearmedizin, Universitatsklinikum Tubingen
    Radiologe 40:938-45. 2000
    ..Further diagnostic improvement might be achieved by use of positron emission tomography which has the potential for absolute quantification of physiological parameters such as renal blood flow in ml.min-1.100 g-1 tissue...
  5. ncbi Unusual distribution of red marrow mimicking chloroma in a patient with acute myelogenous leukemia
    M N Vogel
    Department of Diagnostic Radiology, Eberhard Karls University, Hoppe Seyler Strasse 3, 72076, Tubingen, Germany
    Skeletal Radiol 36:547-50. 2007
    ..Nodular islets of red marrow located in the epiphyseal and distal parts of the limbs may mimic tumoral infiltration and be mistaken for chloroma in a patient with AML...
  6. ncbi [Evaluation of different breathing and contrast-protocols concerning quality and alignment in 18F-FDG PET/CT]
    M N Vogel
    Diagnostische Radiologie, Eberhard Karls Universitat Tubingen
    Rofo 179:72-9. 2007
    ..The purpose of this study was to establish a reliable and simple parameter for alignment evaluation and the evaluation and optimization of state-of-the-art contrast-enhanced examination protocols for (18)F FDG-PET/CT...
  7. ncbi Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging
    A C Pfannenberg
    Department of Diagnostic Radiology, Eberhard Karls University Tuebingen, Hoppe Seyler Strasse 3, 72076 Tuebingen, Germany
    Br J Radiol 80:437-45. 2007
    ..Diagnostic multiphase CT as part of the combined PET/CT protocol has the potential to provide considerable additional value in specific clinical conditions with resultant change of management in a substantial proportion of patients...
  8. ncbi Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol
    M Reimold
    Department of Nuclear Medicine PET Center, University of Tuebingen, Tuebingen, Germany
    Psychopharmacology (Berl) 190:241-9. 2007
    ....
  9. ncbi Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors
    S M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076, Tubingen, Germany
    Eur J Nucl Med Mol Imaging 34:54-9. 2007
    ..In one group, FDG-PET was part of the pretherapeutic staging, whereas in the other group, no PET scans were performed...
  10. ncbi Lymph node gastrinoma in multiple endocrine neoplasia type 1 - a diagnostic challenge
    K Müssig
    Division of Endocrinology, Diabetology, Nephrology, Angiology, and Clinical Chemistry, Department of Internal Medicine, University Hospital of Tubingen, Tubingen, Germany
    Exp Clin Endocrinol Diabetes 116:554-7. 2008
    ..Gastrinomas are the most frequent hormonally-active neuroendocrine tu-mours in patients with multiple endocrine neoplasia type 1 (MEN1)...
  11. ncbi Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study
    S M Eschmann
    University of Tuebingen, Department of Nuclear Medicine, Germany
    Exp Clin Endocrinol Diabetes 114:222-6. 2006
    ..This study analyses prospectively the influence of discontinuing antithyroid drugs (ATD) immediately prior to treatment with radioiodine on the therapeutic outcome...
  12. ncbi Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
    S M Eschmann
    Department of Nuclear Medicine, University of Tubingen, Otfried Mueller Strasse 14, 72076 Tubingen, Germany
    Eur J Nucl Med Mol Imaging 33:263-9. 2006
    ..J Nucl Med 2000;41:85-92). On the basis of these observations, we studied the influence of FDG uptake on prognosis and occurrence of distant metastases in patients with advanced NSCLC...
  13. ncbi Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer
    S M Eschmann
    University of Tuebingen, Department of Nuclear Medicine, Tuebingen, Germany
    Lung Cancer 55:165-71. 2007
    ..Aim of this study was to evaluate FDG-PET for monitoring treatment response during and after neoadjuvant radiochemotherapy (NARCT) in advanced NSCLC...
  14. ncbi Association of somatostatin receptor 2 immunohistochemical expression with [111In]-DTPA octreotide scintigraphy and [68Ga]-DOTATOC PET/CT in neuroendocrine tumors
    K Müssig
    Division of Endocrinology, Department of Internal Medicine, University Hospital of Tubingen, Tubingen, Germany
    Horm Metab Res 42:599-606. 2010
    ..Negativity for SST2, however, does not rule out tracer uptake in some patients, with heterogeneous SST2 expression within the tumor as a potential explanation...
  15. ncbi [Dose-dependent effects of the combined beta/gamma emitter 186-Rhenium on the growth of human vessel wall cells]
    J Wiskirchen
    Abteilung für Radiologische Diagnostik, Eberhard Karls Universitat, Tubingen
    Rofo 173:72-6. 2001
    ..The aim of this study was to evaluate the capability of human aortic smooth musc e cells (HaSMC) and endothelial cells (EC) to recover after incubation with the combined beta/gamma emitter 186rhenium...
  16. ncbi Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET
    C Bokemeyer
    Department of Hematology Oncology, University of Tuebingen Medical Center, Otfried Mueller Str 10, 72076 Tuebingen, Germany
    Br J Cancer 86:506-11. 2002
    ..It may also be a valuable addition to the prognostic model particularly in the good and intermediate group for further selection of patients who will profit from high-dose chemotherapy...
  17. ncbi Rhenium-188 for inhibition of human aortic smooth muscle cell proliferation
    J Wiskirchen
    Department of Diagnostic Radiology, Eberhard Karls University, Hoppe Seyler Str 3, 72076 Tuebingen, Germany
    Int J Radiat Oncol Biol Phys 49:809-15. 2001
    ..To evaluate dose-dependent growth-modulating effects of the beta-gamma emitter Rhenium-188 on cultured human aortic smooth muscle cells (haSMC)...
  18. ncbi FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy
    S M Eschmann
    Department of Nuclear Medicine, University Hospital Tubingen, Roentgenweg 13, Germany
    Eur J Nucl Med Mol Imaging 29:804-8. 2002
    ..FDG PET is the most accurate non-invasive diagnostic procedure for the staging of advanced NSCLC. Therefore use of FDG PET is highly recommended in order to select patients for neoadjuvant or other stage-dependent treatment modalities...
  19. ncbi Combined transmission and emission tomography in a vastus intermedius muscle stress syndrome
    M Horger
    Department of Diagnostic Radiology, , Hoppe-Seyler-Strasse 3, 72076, , Germany
    Eur J Nucl Med Mol Imaging 30:636. 2003
  20. ncbi Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves
    M Reimold
    Department of Nuclear Medicine, University of Tubingen, Otfried Müller Strasse 14, 72076 Tubingen, Germany
    Eur J Nucl Med Mol Imaging 31:564-77. 2004
    ....
  21. ncbi [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker]
    A C Pfannenberg
    Abteilung für Radiologische Diagnostik, Eberhard Karls Universität Tuebingen
    Rofo 176:76-84. 2004
    ..To assess the ability of [(18)F]FDG-PET, CT/MRI and serum tumor marker (TM) for the early prediction of response in patients with metastatic germ cell tumors (GCT) undergoing salvage high-dose chemotherapy (HD-CTX)...
  22. ncbi Local intra-arterial drug delivery for prevention of restenosis: comparison of the efficiency of delivery of different radiopharmaceuticals through a porous catheter
    G Tepe
    Research Laboratories of Schering AG, Berlin, Germany
    Invest Radiol 36:245-9. 2001
    ..The reported efficiency of local drug delivery ranges from 0.001% to 0.1%, with poor retention after 24 hours...
  23. ncbi Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer
    S M Eschmann
    Department of Nuclear Medicine, Eberhard Karls Universitat Tubingen, Germany
    Nuklearmedizin 46:161-8; quiz N47-8. 2007
    ..Aim of this study was to compare the diagnostic accuracy of positron emission tomography and computed tomography with (11)C-Choline (Cho-PET/CT) and whole body magnetic resonance imaging (WB-MRI) for diagnostic work-up of prostate cancer...
  24. ncbi [Imaging findings of angiofollicular lymphoid hyperplasia (Castleman's disease)]
    M Horger
    Rofo 179:991-6. 2007
  25. ncbi [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial
    M de Wit
    Department of Internal Medicine, University Clinic Hamburg Eppendorf, Berlin, Germany
    Ann Oncol 19:1619-23. 2008
    ....
  26. ncbi [Multimodal imaging of pancreatic neuroendocrine tumors]
    K Müssig
    Tubingen
    Rofo 180:373-9. 2008
  27. ncbi [Extra-medullary hematopoiesis: imaging findings]
    M Teufel
    Rofo 180:775-80. 2008
  28. ncbi [11C]Vinblastine syntheses and preliminary imaging in cancer patients
    Christoph Solbach
    Radiopharmacy, PET Center, University Hospital Tubingen, Germany
    J Pharm Pharm Sci 10:266s-276s. 2007
    ....
  29. ncbi [Imaging in hyperparathyroidism]
    M Horger
    Rofo 179:205-7. 2007
  30. ncbi [Large vessel vasculitis as cause of fever of unknown origin (FUO) or systemic inflammation. Diagnosis using 18-F-fluor-2-deoxy-D-glucose positron emission tomography ((18)F-FDG-PET)]
    C C Amberger
    , , Onkologie, Immunologie und Rheumatologie, , , Germany
    Z Rheumatol 64:32-9. 2005
    ..Especially when large vessel vasculitis is suspected, further diagnostic work by PET seems to be of benefit. Furthermore, it offers the opportunity to evaluate disease activity and to check which vessels are involved...
  31. ncbi Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response
    P Reuland
    Department of Nuclear Medicine, , FRG, Germany
    J Pediatr Hematol Oncol 23:437-42. 2001
    ..3 m) than with MAb. The chimeric antibody ch14.18 is likely to be valuable for follow-up examinations and for assessment of therapy response because of earlier detection of new metastases...
  32. ncbi Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma
    H Dittmann
    Department of Nuclear Medicine, University of Tuebingen, Tuebingen, Germany
    Oncol Rep 8:1393-9. 2001
    ..In patients with suspected relapse of HD, FDG-PET seems not to offer any information over CT scans. Using SUVs is not superior to visual assessment of PET alone...
  33. ncbi Assessment of porcine bone metabolism by dynamic
    M Piert
    Department of General Surgery, , , Germany
    J Nucl Med 42:1091-100. 2001
    ..Therefore, it seem reasonable to assume that [(18)F]fluoride ion PET can reduce the number of invasive bone biopsies, thus facilitating follow-up of patients with metabolic bone diseases...
  34. ncbi Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype
    M Reimold
    Department of Nuclear Medicine and PET Center, University of Tubingen, Tubingen, Germany
    J Neural Transm 114:635-9. 2007
    ..In vitro and in vivo evidence suggests that [(11)C]DASB, a new 5-HTT ligand offers some advantages over the ligands used in previous studies in measuring 5-HTT density independent of synaptic levels of serotonin...
  35. ncbi Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study
    M Reimold
    Department of Nuclear Medicine, University of Tubingen, Tubingen, Germany
    J Neural Transm 114:1603-9. 2007
    ..CONCLUSION. This PET study confirms a central role of the serotonergic system, particularly the thalamus in the pathogenesis of obsessive compulsive disorder...
  36. ncbi Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study
    M Reimold
    Department of Nuclear Medicine, University of Tubingen, Tubingen, Germany
    Mol Psychiatry 13:606-13, 557. 2008
    ..In the thalamus, a low serotonin reuptake capacity may interfere with thalamic control of cortical excitability and contribute to anxiety rather than depression per se in major depression...
  37. ncbi [Diagnosis of hyperfunctioning adrenal masses]
    M Horger
    Rofo 178:1171-6. 2006
  38. ncbi Primary squamous cell carcinoma of the thyroid
    K Müssig
    Division of Endocrinology, Metabolism and Pathobiochemistry, Department of Internal Medicine, University Hospital of Tubingen, Tubingen, Germany
    Intern Med J 38:69-70. 2008
  39. ncbi [Imaging findings in multiple endocrine neoplasia type 1 (MEN1).]
    M Horger

    Rofo 179:653-8. 2007